Intuitive Surgical, Inc. $ISRG Shares Sold by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,590 shares of the medical equipment provider’s stock after selling 2,090 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Intuitive Surgical were worth $9,953,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Newbridge Financial Services Group Inc. boosted its holdings in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $28,000. Caitlin John LLC acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $30,000. Finally, Laurel Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $31,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the sale, the director directly owned 239 shares of the company’s stock, valued at $113,156.94. The trade was a 67.66% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 in the last ninety days. 0.60% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Raymond James Financial dropped their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Evercore decreased their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research report on Monday, April 6th. Finally, JPMorgan Chase & Co. lowered their target price on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $573.42.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $406.78 on Friday. Intuitive Surgical, Inc. has a 52 week low of $396.68 and a 52 week high of $603.88. The stock has a market cap of $144.07 billion, a P/E ratio of 49.31, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46. The stock has a 50 day moving average of $438.43 and a 200-day moving average of $490.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.81 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.